#GUTBlog: Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial ,
Posted on April 1, 2025 by philsmith in #GUTBlog
#GUTBlog: Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn’s disease: post hoc analysis of the RISK study ,
Posted on March 21, 2025 by philsmith in #GUTBlog &IBD
#GUTBlog: Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU ,
Posted on March 17, 2025 by philsmith in #GUTBlog &IBD
#GUTBlog: Recent advances in clinical practice: mastering the challenge—managing IBS symptoms in IBD ,
Posted on January 31, 2025 by philsmith in #GUTBlog &IBD
#GUTBlog: Sphincterotomy for biliary sphincter of Oddi disorder and idiopathic acute recurrent pancreatitis: the RESPOnD longitudinal cohort ,
Posted on November 16, 2024 by philsmith in #GUTBlog &Endoscopy &Hepatology
#GUTBlog: Clinical outcomes of potential coeliac disease: a systematic review and meta-analysis ,
Posted on November 1, 2024 by philsmith in #GUTBlog &Endoscopy &Nutrition
#GUTBlog: Environmental impact of single-use versus reusable gastroscopes ,
Posted on October 16, 2024 by philsmith in #GUTBlog &Endoscopy
#GUTBlog: Acute severe ulcerative colitis trials: the past, the present and the future ,
Posted on October 7, 2024 by philsmith in #GUTBlog &IBD
#GUTBlog: Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database ,
Posted on August 13, 2024 by philsmith in #GUTBlog &Endoscopy
#GUTBlog: British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults ,
Posted on July 19, 2024 by philsmith in #GUTBlog &Cirrhosis &Gut Guidelines &Hepatology
